Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Trius Therapeutics Inc | Financial_Report.xls |
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Trius Therapeutics Inc | d270282dex312.htm |
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d270282dex321.htm |
EX-10.7 - OFFER OF EMPLOYMENT - Trius Therapeutics Inc | d270282dex107.htm |
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Trius Therapeutics Inc | d270282dex322.htm |
10-K - FORM 10-K - Trius Therapeutics Inc | d270282d10k.htm |
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d270282dex311.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-168494 and 333-173060) and on Form S-3 (No. 333-176621) of our reports dated March 14, 2012, with respect to the financial statements of Trius Therapeutics, Inc. and the effectiveness of internal control over financial reporting of Trius Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 14, 2011